enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dapagliflozin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin

   Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment

3. Weight Loss Injections: What You Need to Know, From ... - AOL

   www.aol.com/lifestyle/weight-loss-injections...

   An FDA-approved weight loss medication, naltrexone-bupropion is generally considered effective and safe to use. You may experience side effects like dizziness, mood changes, trouble sleeping, and ...

4. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/lifestyle/medications-fda-approved...

   There are seven FDA-approved weight loss medications currently available. These medications are safe and effective and have minimal side effects.

5. Dapagliflozin/saxagliptin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin/saxagliptin

   The most common side effects include upper respiratory tract infection (such as nose and throat infections) and, when used with a sulphonylurea, hypoglycaemia (low ...

6. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

7. FDA approves Eli Lilly diabetes drug for weight loss - AOL

   www.aol.com/fda-approves-eli-lilly-diabetes...

   The FDA approves a new weight loss drug manufactured by Eli Lilly. ... The drug's label warns that side effects include nausea, diarrhea, vomiting, constipation, abdominal pain and fatigue.

8. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   The US Food and Drug Administration (FDA) approves anti-obesity medications as an adjunctive therapy to diet and exercise for people for whom lifestyle changes do not result in sufficient weight loss. In the United States, semaglutide (Wegovy) is approved by the FDA for chronic weight management. [50]

9. What Does This New Diabetes Drug Mean for AstraZeneca and ...

   www.aol.com/news/2014-01-15-new-diabetes-drug...

   Recently, two pharmaceutical giants received FDA approval for a new treatment for type 2 diabetes. Farxiga (dapagliflozin) is a "sodium-glucose co-transporter 2 inhibitor", or SGLT2 inhibitor for ...